English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12340/13424 (92%)
Visitors : 1967745      Online Users : 129
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/14252


    Title: Mesoporous Silica Nanoparticles (MSNs) for cancer theranostics
    Authors: Hsia, Y;Sivasubramanian, M;Chen, NT;Lo, LW
    Contributors: Institute of Biomedical Engineering and Nanomedicine
    Abstract: Optimizing the balance between therapeutic efficacy and side effects is a major challenge in developing drugs. To circumvent unwanted side effects, nanoformulation of drugs for targeted delivery and controlled release is being researched and developed actively in translational nanomedicine. Among the various organic, inorganic, and hybrid nanomaterials used in formulating drugs, mesoporous silica nanoparticles (MSNs) have been drawing increasing attention because they provide a solid framework with a mesoporous structure and a high surface area that can be modified with diverse functional groups to control morphology. MSNs possess 3 topological domains, framework, nanochannels, and outermost surface, each of which can be functionalized sequentially with distinct moieties, making MSN a unique theranostic nanoplatform. The modified functional groups on the surface allow MSNs to be conjugated with diverse targeting molecules, peptides, and aptamers for efficient uptake and accumulation by specific target sites. Furthermore, to release the incorporated drug payload, nanochannels in MSNs can be controlled by varying external and/or internal stimuli, for example by photoirradiating or by altering the pH of subcellular domains and tumor microenvironments. Multifunctionalized MSNs have been proven to be a key platform for 3-in-1 nanotheranostics that orchestrates traceable imaging, targeted delivery, and selective therapeutics for cancer treatments.
    Date: 2016-02-22
    Relation: Nanomaterials for Tumor Targeting Theranostics: A Proactive Clinical Perspective. 2016 Feb 22:143-176.
    Link to: http://dx.doi.org/10.1142/9789814635424_0005
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85128578664
    Appears in Collections:[羅履維] 圖書

    Files in This Item:

    File Description SizeFormat
    SCP85128578664.pdf18924KbAdobe PDF141View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback